| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.08 | 0.004 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.085 | 0.005 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.006 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.006 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |